Literature DB >> 11576202

Is blood homocysteine elevated in migraine?

R Hering-Hanit1, N Gadoth, A Yavetz, S Gavendo, B Sela.   

Abstract

OBJECTIVE: To determine total serum homocysteine levels in a large group of patients with migraine with and without aura.
BACKGROUND: Hypercoagulable state is a known risk factor for stroke in the young. The existence of a hypercoagulable state has been postulated in migraine and homocysteinemia with young-onset stroke. To the best of our knowledge, blood homocysteine has not been studied in a significant number of patients with various forms of migraine.
METHODS: Total serum homocysteine was measured with high-performance liquid chromatography in 78 patients with migraine and in 126 age- and sex-matched healthy volunteers.
RESULTS: Seventy-eight patients aged 18 to 65 years were studied: 22 with migraine with aura and 56 with migraine without aura. Only 1 man had significantly elevated blood homocysteine (38.6 micromol/L), while another had a borderline elevation (15.8 micromol/L) (reference value for both sexes in our laboratory is 4 to 14 micromol/L). Both patients suffered from migraine without aura.
CONCLUSIONS: Blood homocysteine is not elevated in migraine.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11576202     DOI: 10.1046/j.1526-4610.2001.01143.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  9 in total

1.  Thrombophilic alterations, migraine, and vascular disease: results from a case-control study.

Authors:  Cinzia Cavestro; Diana Degan; Gianmatteo Micca; Raffaele Aloi; Silvia Mandrino; Maria Cristina Frigeri; Francesca Pistoia; Filippo Molinari; Simona Sacco
Journal:  Neurol Sci       Date:  2021-01-20       Impact factor: 3.307

2.  Risk factors of vestibular migraine-related brain white matter lesions.

Authors:  Yu Shen; Defu Li; Qian Cao; Mengyao Hu; Zhou Hou; Lijun Xu; Yanping Li; Daojun Hong
Journal:  Acta Neurol Belg       Date:  2022-09-07       Impact factor: 2.471

Review 3.  Migraine and stroke: from a questioned relationship to a supported comorbidity.

Authors:  Maria Carola Narbone; Santo Gangemi; Maria Abbate
Journal:  Neurol Sci       Date:  2008-05       Impact factor: 3.307

4.  Investigation of MTHFR C677T gene polymorphism, biochemical and clinical parameters in Turkish migraine patients: association with allodynia and fatigue.

Authors:  Anzel Bahadir; Recep Eroz; Suber Dikici
Journal:  Cell Mol Neurobiol       Date:  2013-08-22       Impact factor: 5.046

5.  Risk factors of migraine-related brain white matter hyperintensities: an investigation of 186 patients.

Authors:  Anita Trauninger; Eszter Leél-Ossy; David Olayinka Kamson; László Pótó; Mihály Aradi; Ferenc Kövér; Marianna Imre; Hedvig Komáromy; Szilvia Erdélyi-Botor; Agnes Patzkó; Zoltán Pfund
Journal:  J Headache Pain       Date:  2011-02-18       Impact factor: 7.277

6.  Association between serum levels of homocysteine with characteristics of migraine attacks in migraine with aura.

Authors:  Omid Sadeghi; Zahra Maghsoudi; Gholamreza Askari; Fariborz Khorvash; Awat Feizi
Journal:  J Res Med Sci       Date:  2014-11       Impact factor: 1.852

7.  Migraine and genetic polymorphisms: an overview.

Authors:  Vincenzo Pizza; Anella Agresta; Antonio Agresta; Eros Lamaida; Norman Lamaida; Francesco Infante; Anna Capasso
Journal:  Open Neurol J       Date:  2012-08-17

8.  The methylenetetrahydrofolate reductase gene variant C677T influences susceptibility to migraine with aura.

Authors:  Rod A Lea; Micky Ovcaric; James Sundholm; John MacMillan; Lyn R Griffiths
Journal:  BMC Med       Date:  2004-02-12       Impact factor: 8.775

Review 9.  Thrombophilic disorders in migraine.

Authors:  Cinzia Cavestro; Silvia Mandrino
Journal:  Front Neurol       Date:  2014-07-10       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.